Home › NDC Lookup › RxCUI directory › RxCUI 562806

Pimecrolimus 10 MG/ML Topical Cream — RxCUI 562806

RxNorm drug concept · Semantic clinical drug
RxCUI 562806 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI562806
Official namePimecrolimus 10 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspimecrolimus 1 % Topical Cream
FDA products mapped6
Package NDCs mapped10
Reported Medicaid activity (SDUD)90,855 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pimecrolimus Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's used to treat mild to moderate atopic dermatitis — that's eczema. But it's considered a second-line option, meaning your doctor will typically try other topical prescription t...
  • What is pimecrolimus cream actually used for?
  • Apply a thin layer to just the skin areas affected by your eczema, twice a day. You don't need to cover large areas — just where the rash is. Once your skin clears up and the itchi...
  • This is a real warning worth knowing about, but it's important to keep it in perspective. Rare cases of skin cancer and lymphoma have been reported in people using this type of med...
📖 Read our full Pimecrolimus Topical guide →

🕸️ Concept Web — How Pimecrolimus 10 MG/ML Topical Cream Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pimecrolimus 10 MG/ML Topical Cream RxCUI 562806

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Pimecrolimus 321952
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Elidel 306865
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pimecrolimus Topical Cream 562805
    • Pimecrolimus Topical Product 1158739
    • Pimecrolimus Topical Cream [Elidel] 362079
    • Elidel Topical Product 1173873
    • Topical Cream 316982
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Pimecrolimus 10 MG/ML 358807
    • Pimecrolimus 10 MG/ML Topical Cream [Elidel] 352085
    • Pimecrolimus 10 MG/ML [Elidel] 575829

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pimecrolimus 10 MG/ML SCDC · 358807
  • Pimecrolimus Topical Cream SCDF · 562805
  • Pimecrolimus Topical Product SCDG · 1158739

Brand-Name Concepts

  • Pimecrolimus 10 MG/ML Topical Cream [Elidel] SBD · 352085
  • Pimecrolimus 10 MG/ML [Elidel] SBDC · 575829
  • Pimecrolimus Topical Cream [Elidel] SBDF · 362079
  • Elidel Topical Product SBDG · 1173873
  • Elidel BN · 306865

📦 FDA Products & Package NDCs

6 products · 10 package NDCs
10 package NDCs map to RxCUI 562806 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00591-2944-30 30 g in 1 TUBE (0591-2944-30) pimecrolimus Actavis Pharma, Inc. 2018-12-27
00591-2944-60 60 g in 1 TUBE (0591-2944-60) pimecrolimus Actavis Pharma, Inc. 2018-12-27
00591-2944-87 100 g in 1 TUBE (0591-2944-87) pimecrolimus Actavis Pharma, Inc. 2018-12-27
68462-0609-35 1 TUBE in 1 CARTON (68462-609-35) / 30 g in 1 TUBE Pimecrolimus Glenmark Pharmaceuticals Inc., USA 2019-08-29
68462-0609-65 1 TUBE in 1 CARTON (68462-609-65) / 60 g in 1 TUBE Pimecrolimus Glenmark Pharmaceuticals Inc., USA 2019-08-29
68462-0609-94 1 TUBE in 1 CARTON (68462-609-94) / 100 g in 1 TUBE Pimecrolimus Glenmark Pharmaceuticals Inc., USA 2019-08-29
68682-0110-01 1 TUBE in 1 CARTON (68682-110-01) / 30 g in 1 TUBE Pimecrolimus Oceanside Pharmaceuticals 2018-11-26
68682-0111-02 1 TUBE in 1 CARTON (68682-111-02) / 60 g in 1 TUBE Pimecrolimus Oceanside Pharmaceuticals 2018-11-26
68682-0112-03 1 TUBE in 1 CARTON (68682-112-03) / 100 g in 1 TUBE Pimecrolimus Oceanside Pharmaceuticals 2018-11-26
71335-2988-01 1 TUBE in 1 CARTON (71335-2988-1) / 30 g in 1 TUBE Pimecrolimus Bryant Ranch Prepack 2025-11-10
Observed labelers: Actavis Pharma, Inc. (3) · Glenmark Pharmaceuticals Inc., USA (3) · Oceanside Pharmaceuticals (3) · Bryant Ranch Prepack (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$3.3089
Range $3.1461–$3.4290 · middle 50% $3.1868–$3.3989 · 6 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.